StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)

Close on Nov 17, 2026Market cap $13.19MP/E –Yield –

Lipocine EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Lipocine's EV/EBITDA was 3.9× on Jan 31, 2023.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20233.9×+3.6
2022Dec 30, 20220.3×–

More Lipocine figures

See a number that looks wrong?